{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:12:28Z","timestamp":1791821548424,"version":"4.3.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"\u4e2d\u56fd","award":["No. ZDXK2021006"],"award-info":[{"award-number":["No. ZDXK2021006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-85218-5","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T03:00:54Z","timestamp":1736132454000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between metabolic dysfunction associated steatotic liver disease and gallstones in the US population using propensity score matching"],"prefix":"10.1038","volume":"15","author":[{"given":"Yingying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaobo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"85218_CR1","unstructured":"Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. (2023)."},{"key":"85218_CR2","doi-asserted-by":"publisher","first-page":"e13110","DOI":"10.1002\/jgh3.13110","volume":"8","author":"T Miwa","year":"2024","unstructured":"Miwa, T. et al. Usefulness of health checkup-based indices in identifying metabolic dysfunction-associated steatotic liver disease. JGH Open: Open. Access. J. Gastroenterol. Hepatol. 8, e13110 (2024).","journal-title":"JGH Open: Open. Access. J. Gastroenterol. Hepatol."},{"key":"85218_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tem.2024.02.007","volume":"35","author":"L Miao","year":"2024","unstructured":"Miao, L., Targher, G., Byrne, C. D., Cao, Y. Y. & Zheng, M. H. Current status and future trends of the global burden of MASLD. Trends Endocrinol. Metab. 35, 697\u2013707 (2024).","journal-title":"Trends Endocrinol. Metab."},{"key":"85218_CR4","doi-asserted-by":"crossref","unstructured":"Chen, L., Tao, X., Zeng, M., Mi, Y. & Xu, L. Clinical and histological features under different nomenclatures of fatty liver disease: NAFLD, MAFLD, MASLD and MetALD. J. Hepatol. 80, e64\u2013e66 (2024).","DOI":"10.1016\/j.jhep.2023.08.021"},{"key":"85218_CR5","doi-asserted-by":"crossref","unstructured":"Perazzo, H., Pacheco, A. G. & Griep, R. H. Changing from NAFLD through MAFLD to MASLD: Similar prevalence and risk factors in a large Brazilian cohort. J. Hepatol. 80, e72\u2013e74 (2024).","DOI":"10.1016\/j.jhep.2023.08.025"},{"key":"85218_CR6","first-page":"2425","volume":"43","author":"S Ciardullo","year":"2023","unstructured":"Ciardullo, S., Carbone, M., Invernizzi, P. & Perseghin, G. Exploring the landscape of steatotic liver disease in the general US population. Liver Int. Off. J. Int. Assoc. Study Liver. 43, 2425\u20132433 (2023).","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"85218_CR7","doi-asserted-by":"publisher","first-page":"172","DOI":"10.5009\/gnl.2012.6.2.172","volume":"6","author":"LM Stinton","year":"2012","unstructured":"Stinton, L. M. & Shaffer, E. A. Epidemiology of gallbladder disease: Cholelithiasis and cancer. Gut Liver. 6, 172\u2013187 (2012).","journal-title":"Gut Liver"},{"key":"85218_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12876-017-0678-6","volume":"17","author":"JC Figueiredo","year":"2017","unstructured":"Figueiredo, J. C. et al. Sex and ethnic\/racial-specific risk factors for gallbladder disease. BMC Gastroenterol. 17, 153 (2017).","journal-title":"BMC Gastroenterol."},{"key":"85218_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.bpg.2006.05.004","volume":"20","author":"EA Shaffer","year":"2006","unstructured":"Shaffer, E. A. Gallstone disease: Epidemiology of gallbladder stone disease. Best Pract. Res. Clin. Gastroenterol. 20, 981\u2013996 (2006).","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"85218_CR10","first-page":"99","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal, R. & Shaffer, E. A. Gallbladder cancer: Epidemiology and outcome. Clin. Epidemiol. 6, 99\u2013109 (2014).","journal-title":"Clin. Epidemiol."},{"key":"85218_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jhep.2016.03.005","volume":"65","author":"EASL Clinical Practice Guidelines on the","year":"2016","unstructured":"EASL Clinical Practice Guidelines on the. Prevention, diagnosis and treatment of gallstones. J. Hepatol. 65, 146\u2013181 (2016).","journal-title":"J. Hepatol."},{"key":"85218_CR12","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1097\/HEP.0000000000000264","volume":"77","author":"A Unalp-Arida","year":"2023","unstructured":"Unalp-Arida, A. & Ruhl, C. E. Increasing gallstone disease prevalence and associations with gallbladder and biliary tract mortality in the US. Hepatology 77, 1882\u20131895 (2023).","journal-title":"Hepatology"},{"key":"85218_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/17474124.2023.2175671","volume":"17","author":"S Gu","year":"2023","unstructured":"Gu, S. et al. Bidirectional association between NAFLD and gallstone disease: A systematic review and meta-analysis of observational studies. Expert Rev. Gastroenterol. Hepatol. 17, 283\u2013293 (2023).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"85218_CR14","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3109\/00365521.2011.643481","volume":"47","author":"T Koller","year":"2012","unstructured":"Koller, T., Kollerova, J., Hlavaty, T., Huorka, M. & Payer, J. Cholelithiasis and markers of nonalcoholic fatty liver disease in patients with metabolic risk factors. Scand. J. Gastroenterol. 47, 197\u2013203 (2012).","journal-title":"Scand. J. Gastroenterol."},{"key":"85218_CR15","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1440-1746.2005.03924.x","volume":"20","author":"P Loria","year":"2005","unstructured":"Loria, P. et al. Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors. J. Gastroenterol. Hepatol. 20, 1176\u20131184 (2005).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"85218_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12876-014-0213-y","volume":"14","author":"J Liu","year":"2014","unstructured":"Liu, J. et al. Non-alcoholic fatty liver disease associated with gallstones in females rather than males: A longitudinal cohort study in Chinese urban population. BMC Gastroenterol. 14, 213 (2014).","journal-title":"BMC Gastroenterol."},{"key":"85218_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.5009\/gnl.2014.8.3.313","volume":"8","author":"Y Yilmaz","year":"2014","unstructured":"Yilmaz, Y. et al. Gallstone disease does not predict liver histology in nonalcoholic fatty liver disease. Gut Liver. 8, 313\u2013317 (2014).","journal-title":"Gut Liver"},{"key":"85218_CR18","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ajg.2013.70","volume":"108","author":"CE Ruhl","year":"2013","unstructured":"Ruhl, C. E. & Everhart, J. E. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am. J. Gastroenterol. 108, 952\u2013958 (2013).","journal-title":"Am. J. Gastroenterol."},{"key":"85218_CR19","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.3748\/wjg.v11.i11.1653","volume":"11","author":"N M\u00e9ndez-S\u00e1nchez","year":"2005","unstructured":"M\u00e9ndez-S\u00e1nchez, N. et al. Metabolic syndrome as a risk factor for gallstone disease. World J. Gastroenterol. 11, 1653\u20131657 (2005).","journal-title":"World J. Gastroenterol."},{"key":"85218_CR20","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.3748\/wjg.v18.i31.4215","volume":"18","author":"LY Chen","year":"2012","unstructured":"Chen, L. Y. et al. Metabolic syndrome and gallstone disease. World J. Gastroenterol. 18, 4215\u20134220 (2012).","journal-title":"World J. Gastroenterol."},{"key":"85218_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/1471-2296-15-138","volume":"15","author":"IC Lin","year":"2014","unstructured":"Lin, I. C. et al. The association of metabolic syndrome and its factors with gallstone disease. BMC Fam. Pract. 15, 138 (2014).","journal-title":"BMC Fam. Pract."},{"key":"85218_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcn\/80.1.1","volume":"80","author":"SM Grundy","year":"2004","unstructured":"Grundy, S. M. Cholesterol gallstones: A fellow traveler with metabolic syndrome? Am. J. Clin. Nutr. 80, 1\u20132 (2004).","journal-title":"Am. J. Clin. Nutr."},{"key":"85218_CR23","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1080\/00365521.2017.1365166","volume":"52","author":"DM Shabanzadeh","year":"2017","unstructured":"Shabanzadeh, D. M., Skaaby, T., S\u00f8rensen, L. T., Eugen-Olsen, J. & J\u00f8rgensen, T. Metabolic biomarkers and gallstone disease - a population-based study. Scand. J. Gastroenterol. 52, 1270\u20131277 (2017).","journal-title":"Scand. J. Gastroenterol."},{"key":"85218_CR24","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1007\/s11739-023-03355-z","volume":"18","author":"P Portincasa","year":"2023","unstructured":"Portincasa, P. et al. Metabolic dysfunction-associated gallstone disease: Expecting more from critical care manifestations. Intern. Emerg. Med. 18, 1897\u20131918 (2023).","journal-title":"Intern. Emerg. Med."},{"key":"85218_CR25","doi-asserted-by":"publisher","first-page":"1025854","DOI":"10.3389\/fendo.2022.1025854","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang, J. et al. Association of METS-IR index with prevalence of gallbladder stones and the age at the first gallbladder stone surgery in US adults: A cross-sectional study. Front. Endocrinol. (Lausanne). 13, 1025854 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"85218_CR26","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.2147\/DMSO.S266947","volume":"13","author":"MC Hung","year":"2020","unstructured":"Hung, M. C. et al. Relationship between gallstone disease and cardiometabolic risk factors in Elderly people with non-alcoholic fatty liver disease. Diabetes Metab. Syndr. Obes. 13, 3579\u20133585 (2020).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"85218_CR27","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5152\/tjg.2017.09","volume":"28","author":"SS Shen","year":"2017","unstructured":"Shen, S. S. et al. Promotional effect of nonalcoholic fatty liver disease on gallstone disease: A systematic review and meta-analysis. Turk. J. Gastroenterol. Off. J. Turk. Soc. Gastroenterol. 28, 31\u201339 (2017).","journal-title":"Turkish J. Gastroenterology: Official J. Turkish Soc. Gastroenterol."},{"key":"85218_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.gtc.2016.07.010","volume":"45","author":"Z Cruz-Monserrate","year":"2016","unstructured":"Cruz-Monserrate, Z., Conwell, D. L. & Krishna, S. G. The impact of obesity on gallstone disease, acute pancreatitis, and pancreatic cancer. Gastroenterol. Clin. N. Am. 45, 625\u2013637 (2016).","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"85218_CR29","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/hepr.13906","volume":"53","author":"T Miwa","year":"2023","unstructured":"Miwa, T. et al. Impact of body fat accumulation on metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease in Japanese male young adults. Hepatol. Res. Off. J. Japan Soc. Hepatol. 53, 691\u2013700 (2023).","journal-title":"Hepatol. Res. Off. J. Japan Soc. Hepatol."},{"key":"85218_CR30","doi-asserted-by":"publisher","first-page":"1180903","DOI":"10.3389\/fendo.2023.1180903","volume":"14","author":"Q Zhu","year":"2023","unstructured":"Zhu, Q. et al. Causal association between metabolic syndrome and cholelithiasis: A mendelian randomization study. Front. Endocrinol. (Lausanne). 14, 1180903 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"85218_CR31","doi-asserted-by":"publisher","first-page":"1189553","DOI":"10.3389\/fendo.2023.1189553","volume":"14","author":"G Zhang","year":"2023","unstructured":"Zhang, G. et al. Higher visceral adiposity index was associated with an elevated prevalence of gallstones and an earlier age at first gallstone surgery in US adults: The results are based on a cross-sectional study. Front. Endocrinol. (Lausanne). 14, 1189553 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"85218_CR32","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41598-023-28088-z","volume":"13","author":"L Jiang","year":"2023","unstructured":"Jiang, L., Du, J., Wang, J. & Ding, J. Sex-specific differences in the associations of metabolic syndrome or components with gallstone disease in Chinese euthyroid population. Sci. Rep. 13, 1081 (2023).","journal-title":"Sci. Rep."},{"key":"85218_CR33","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12902-021-00899-z","volume":"21","author":"Y Lu","year":"2021","unstructured":"Lu, Y. et al. Gallstone disease and nonalcoholic fatty liver disease in patients with type 2 diabetes: A cross-sectional study. BMC Endocr. Disord. 21, 231 (2021).","journal-title":"BMC Endocr. Disord"},{"key":"85218_CR34","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.clinre.2024.102363","volume":"48","author":"G Zhao","year":"2024","unstructured":"Zhao, G. et al. Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study. Clin. Res. Hepatol. Gastroenterol. 48, 102363 (2024).","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"85218_CR35","doi-asserted-by":"crossref","unstructured":"Luo, N., Zhang, X., Huang, J., Chen, H. & Tang, H. Prevalence of steatotic liver disease and associated fibrosis in the United States: Results from NHANES 2017-March 2020. J. Hepatol. (2023).","DOI":"10.1016\/j.jhep.2023.08.019"},{"key":"85218_CR36","doi-asserted-by":"publisher","first-page":"1276465","DOI":"10.3389\/fendo.2023.1276465","volume":"14","author":"B Ke","year":"2023","unstructured":"Ke, B., Sun, Y., Dai, X., Gui, Y. & Chen, S. Relationship between weight-adjusted waist circumference index and prevalence of gallstones in U.S. adults: A study based on the NHANES 2017\u20132020. Front. Endocrinol. (Lausanne). 14, 1276465 (2023).","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"85218_CR37","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui, M. S. et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 17, 156\u2013163e152 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"85218_CR38","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13054-019-2309-9","volume":"23","author":"Y Shen","year":"2019","unstructured":"Shen, Y., Zhang, W. & Shen, Y. Early diuretic use and mortality in critically ill patients with vasopressor support: A propensity score-matching analysis. Crit. Care. (London, England). 23, 9 (2019).","journal-title":"Crit. Care. (London, England)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85218-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85218-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85218-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T15:02:57Z","timestamp":1736175777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-85218-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["85218"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-85218-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The authors affirm that there are no conflicts of interest, including any commercial or financial relationships that could potentially bias the research findings.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"910"}}